This trial is testing a drug to see if it can help people with kidney disease who have moderate to severe itchiness. The trial has two parts, the first is 12 weeks to see if the drug works and the second is up to 52 weeks to see if the drug has any long term effects.
1 Primary · 4 Secondary · Reporting Duration: Week 12 of Treatment Period 1
400 Total Participants · 2 Treatment Groups
Primary Treatment: Difelikefalin 1 mg Oral Tablet · Has Placebo Group · Phase 3
Age 18 - 85 · All Participants · 5 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: